000 | 01184 a2200313 4500 | ||
---|---|---|---|
005 | 20250516082241.0 | ||
264 | 0 | _c20120508 | |
008 | 201205s 0 0 eng d | ||
022 | _a1532-6535 | ||
024 | 7 |
_a10.1038/clpt.2011.349 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiller, D H | |
245 | 0 | 0 |
_aAdvances in imaging to support the development of novel therapies for multiple sclerosis. _h[electronic resource] |
260 |
_bClinical pharmacology and therapeutics _cApr 2012 |
||
300 |
_a621-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDiagnostic Imaging _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
650 | 0 | 4 |
_aMultiple Sclerosis _xdiagnosis |
650 | 0 | 4 |
_aOptic Neuritis _xdiagnosis |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 |
_aTomography, Optical Coherence _xmethods |
700 | 1 | _aAltmann, D R | |
700 | 1 | _aChard, D T | |
773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 91 _gno. 4 _gp. 621-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2011.349 _zAvailable from publisher's website |
999 |
_c21604594 _d21604594 |